BSGM · Biosig Technologies Inc

-

Please sign in to comment on BSGM

1 Comment

Admin

4 years, 1 month ago

BioSig Technologies, Inc is currently in a long term downtrend where the price is trading 9.9% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

BioSig Technologies, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has increased by 30.4% to $-10M since the same quarter in the previous year.

Finally, its free cash flow fell by 53.5% to $-6M since the same quarter in the previous year.

Based on the above factors, BioSig Technologies, Inc gets an overall score of 2/5.

Exchange	OTCQB
CurrencyCode	USD
ISIN	US09073N2018
Sector	Healthcare
Industry	Medical Devices

Target Price	2.5
Market Cap	33M
PE Ratio	None
Beta	0.02
Dividend Yield	None

ABOUT

Biosig Technologies Inc

BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BSGM · Biosig Technologies Inc

-

Biosig Technologies Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Biosig Technologies Inc using a moving average strategy